Inflammation is implicated in the pathogenesis of cardiovascular disease. However, whether and how inflammation contributes to autonomic dysfunction remain poorly characterized. We previously demonstrated that IFNγ causes retraction of dendritic processes in cultures of sympathetic neurons dissociated from rat superior cervical ganglia. Based on these observations, we hypothesized that IFNγ similarly disrupts connectivity of postganglionic sympathetic neurons in vivo. To test this hypothesis, young adult male Sprague Dawley rats were administered purified recombinant rat IFNγ to at levels reported during acute or chronic neuroinflammatory states. Relative to vehicle controls, dendritic arborization and synapse density were significantly reduced in sympathetic neurons of SCG from IFNγ-treated animals. IFNγ-induced loss of receptive surface in the SCG occurred in the absence of reduced neuronal cell viability or decreased trophic interactions between SCG neurons and target tissues. Decreased dendritic complexity and synapse loss was coincident with impaired ganglionic neurotransmission as evidenced by an attenuated baroreflex in animals treated with IFNγ. Based on these observations we propose a novel pathogenic mechanism of neuroinflammatory cardiovascular disease in which IFNγ disrupts neuronal connectivity via selective retraction of dendrites of autonomic neurons, leading to decreased sympathetic excitability.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Autonomic Neuroscience: Basic and Clinical
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Received: May 15, 2013
© 2013 Published by Elsevier Inc.